Human primary tumor cells derived from patients with MYCN-amplified high-risk neuroblastoma were implanted orthotopically in the retroperitoneal periadrenal space of mice, which modeled the typical anatomic site and microenvironment of human disease. The gene discussed is MYCN; the disease is neuroblastoma.